Evidence map›Paper›PMID 40124307›Full record

ArticleOphthalmology science

OCT Angiography-Derived Retinal Capillary Perfusion Measures in the Framingham Heart Study.

Ana D Collazo Martinez, Shu Jie Ting, Anoush Shahidzadeh, Brinda Vaidya, Tim Kowalczyk, Muhammed Alluwimi, Sujata Rijal, Xuejuan Jiang, Ruikang Wang, Alexa Beiser and 3 more

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Association of epiretinal membranes with disability in people with multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ana D Collazo MartinezDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.
Shu Jie TingDepartment of Neurology, The Framingham Heart Study, Framingham, Massachusetts.
Anoush ShahidzadehDepartment of Ophthalmology, Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Brinda VaidyaDepartment of Neurology, The Framingham Heart Study, Framingham, Massachusetts.
Tim KowalczykDepartment of Neurology, The Framingham Heart Study, Framingham, Massachusetts.
Muhammed AlluwimiDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.
Sujata RijalDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.
Xuejuan JiangDepartment of Ophthalmology, Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Ruikang WangDepartment of Bioengineering, University of Washington, Seattle, Washington.
Alexa BeiserDepartment of Neurology, The Framingham Heart Study, Framingham, Massachusetts.
Lucia SobrinDepartment of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
Sudha SeshadriDepartment of Neurology, The Framingham Heart Study, Framingham, Massachusetts.
Amir H KashaniDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.

Funding

Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) studyR01AG060942 · NIA · WASHINGTON UNIVERSITY · PI Cecilia Sungmin Lee · 2019 to 2026
$39.4M
FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham CohortsR01AG054076 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DECARLI, CHARLES, SESHADRI, SUDHA · 2016 to 2020
$12.3M
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approachesU01AG058589 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOERWINKLE, ERIC A., DE JAGER, PHILIP L · 2018 to 2022
$11.1M
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and ResilienceR01AG066524 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KASHANI, AMIR H, RAMACHANDRAN, VASAN S · 2020 to 2024
$9.7M
Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC)RF1AG059421 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SESHADRI, SUDHA · 2018 to 2018
$6.1M
Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC)R01AG059421 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Stephanie Anne-Carine Debette, Carole Dufouil · 2026 to 2026
$4.7M
Plasma Proteome and Risk of Alzheimer Dementia and Related Endophenotypes in the Framingham StudyRF1AG063507 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GERSZTEN, ROBERT E, RAMACHANDRAN, VASAN S · 2019 to 2019
$4.2M
Imaging Genomics of the Aging BrainR01AG058464 · NIA · YALE UNIVERSITY · PI BLANGERO, JOHN, GLAHN, DAVID C · 2018 to 2022
$3.9M
SARS-CoV-2 and Precursors of Alzheimer's Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational CohortR56AG074467 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GIRARD, TIMOTHY D, HOSSEINI, AKRAM A. · 2021 to 2021
$3.5M
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based MetricsR01EY030564 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KASHANI, AMIR H · 2019 to 2024
$3.5M
NEI NIH HHS R01 EY028753NEI NIH HHS R01 EY030564NHLBI NIH HHS 75N92019D00031NIA NIH HHS P30 AG066546NIA NIH HHS R01 AG054076NIA NIH HHS R01 AG058464NIA NIH HHS R01 AG059421NIA NIH HHS R01 AG060942NIA NIH HHS R01 AG066524NIA NIH HHS R56 AG074467NIA NIH HHS RF1 AG059421NIA NIH HHS RF1 AG061872NIA NIH HHS RF1 AG063507NIA NIH HHS U01 AG052409NIA NIH HHS U01 AG058589NINDS NIH HHS UF1 NS125513NINDS NIH HHS UH3 NS100605
6 · The paper itself

Abstract

Purpose: To report baseline demographic associations and novel intereye correlations of retinal perfusion in the Framingham Heart Study (FHS). Design: Cross-sectional study. Participants: One thousand eighteen participants were recruited. Of these, 962 participants (mean age 75 ± 7, 59% female, 1720 undilated eyes) had any OCT angiography (OCTA) data. Methods: Participants from the community-based FHS were recruited between 2020 and 2022. Foveal-centered 3 × 3 mm Main Outcome Measures: Vessel skeleton density, VAD, and flux. Results: One thousand two hundred forty-four eyes (73%) had usable OCTA data with 52% acquired from the right eye. Although there was a significant correlation of retinal perfusion measures between 2 eyes of an individual, this was only moderate in magnitude (R = 0.6, Conclusions: Retinal capillary perfusion measures between 2 eyes of an individual share only moderate correlation even after adjusting for image quality and scan level artifacts. This has important implications in study design and interpretation of data from unilaterally performed studies on the retinal circulation. These data suggest that intereye differences in retinal perfusion have physiological and disease-related causes that warrant further investigation. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Capillary densityFramingham Heart StudyOCTARetina

Identifiers

PMID40124307
PMCPMC11926700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.